Terms ending in 2037
Every in-force patent on Ncan Genomics, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,286,671 | Linked Target Capture In force · High confidence | Ncan Genomics, Inc. | In force | High confidence | |
| US 12,291,747 | Linked Target Capture In force · High confidence | Ncan Genomics, Inc. | In force | High confidence | |
| US 12,338,493 | Linked Target Capture In force · High confidence | Ncan Genomics, Inc. | In force | High confidence | |
| US 12,359,251 | Linked Target Capture In force · High confidence | Ncan Genomics, Inc. | In force | High confidence | |
| US 10,801,059 | Droplet-Based Linked-Fragment Sequencing In force · High confidence | Ncan Genomics, Inc. | In force | High confidence | |
| US 10,961,568 | Linked Target Capture In force · High confidence | Ncan Genomics, Inc. | In force | High confidence | |
| US 10,961,573 | Linked Duplex Target Capture In force · High confidence | Ncan Genomics, Inc. | In force | High confidence | |
| US 11,905,556 | Linked Target Capture In force · High confidence | Ncan Genomics, Inc. | In force | High confidence | |
| US 11,021,742 | Linked-Fragment Sequencing In force · High confidence | Ncan Genomics, Inc. | In force | High confidence | |
| US 12,344,888 | Linked Ligation In force · High confidence | Ncan Genomics, Inc. | In force | High confidence | |
| 2 more term ends in 2037 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.